| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 05/05/2005 | US20050096470 novel intermediate (5-substituted) (6-substituted) 6H-imidazo[4,5-c]tetrazolo[1,5-a]quinoline compounds of given formula; intermediate to antiviral immunomodulator 1H-imidazo[4,5-c]quinolin-4-amines |
| 05/05/2005 | US20050096468 Inhibitors of histone deacetylase |
| 05/05/2005 | US20050096348 non-insulin dependent diabetes mellitus, and impaired glucose tolerance; dipeptidyl peptidase IV (DPP-IV) inhibitors eg (2S)-1-{[(1S)-2-(5-cyano-2-methyl-indol-1-yl)-1-methyl-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile |
| 05/05/2005 | US20050096345 Substituted tetrahydro-1H-pyrazolo [3,4-c] pyridines, compositions comprising them, and use |
| 05/05/2005 | US20050096343 pharmocophores of quinolone and oxazolidinone chemicaly linked; against a variety of multi-drag resistant bacteria; staphylococci, enterococci, Moraxella catarrhalis, haemophilus influenza, bacteroides, Clostridia, Mycobacterium tuberculosis, Mycobacterium avium |
| 05/05/2005 | US20050096338 Camptothecin analogs having an E-ring ketone |
| 05/05/2005 | US20050096335 Heteroaryl - fused nitrogen heterocycles as therapeutic agents |
| 05/05/2005 | US20050096333 Quinazoline derivatives as medicaments |
| 05/05/2005 | US20050096327 eg 2-(4-Methyl-piperazin-1-yl)-4-phenyl-quinazoline; attention deficit hyperactivity disorder |
| 05/05/2005 | US20050096325 use of specified inhibitors of chemokine receptors to treat inflammatory diseases such as asthma, allergic rhinitis, atopic dermatitis, inflammatory bowel diseases, idiopathic pulmonary fibrosis, bullous pemphigoid, allergic colitis, eczema, conjunctivitis, familial eosinophilia |
| 05/05/2005 | US20050096323 clot-bound thrombin as well as fluid-phase; anticoagulant; oral bioavailability; thrombosis; heparin-induced thrombocytopenia (HIT); small molecule; 3-(1,2,3,4-tetrahydro-3methyl-8-quinolinesulfonyl) pyrido(1,2-a)pyrazine 1,4-dione compounds |
| 05/05/2005 | US20050096310 Antagonist of phosphorylation of myosin regulatory light chain, enzyme inhibitors; therapeutic treatment of glaucoma, bronchial asthma, chronic obstructive pulmonary disease, nervous system disorders; 4-(2,3-dihydro-1,5-diazaphenalen-1-yl)cyclohexylamine |
| 05/05/2005 | US20050096298 Purine compounds for treatment of bone disorders or cancer |
| 05/05/2005 | US20050096297 Antibacterial agents |
| 05/05/2005 | US20050096278 Antibacterial agents |
| 05/05/2005 | US20050092452 Such as 1-butyl-3-hydroxy-1-[2-hydroxy-3-(1-oxyl-2,2,6,6-tetramethyl-piperidin-4-yloxy)-propyl]-azetidinium chloride; yellowing and discoloration prevention; ultraviolet, fluorescent and solar light stability; expanding use of high yield pulps to higher grade products |
| 05/04/2005 | EP1528062A2 Process for the preparation of s-type 4-substituted hydroxypyranoindolidine compounds |
| 05/04/2005 | EP1528061A1 Heterocyclic derivatives which inhibit factor Xa |
| 05/04/2005 | EP1527075A1 Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands |
| 05/04/2005 | EP1527050A1 Quinoline derivatives and their use as mycobacterial inhibitors |
| 05/04/2005 | EP1526895A2 Methods for treating carbonic anhydrase mediated disorders |
| 05/04/2005 | EP1526869A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia |
| 05/04/2005 | EP1526852A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 05/04/2005 | EP1448553B1 N-heterocyclyl hydrazides as neurotrophic agents |
| 05/04/2005 | EP1404673B1 Technical synthesis method for producing tropenol |
| 05/04/2005 | EP1317448B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/04/2005 | EP1127057B1 Naphthyridine compounds and thier azaisosteric analogues as antibacterials |
| 05/04/2005 | EP0882048B1 3-alkylimidazopyridines |
| 05/04/2005 | CN1612877A Spiroazacyclic compounds as monoamine receptor modulators |
| 05/04/2005 | CN1612876A Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1] octane, the preparation thereof and the application of same in therapeutics |
| 05/04/2005 | CN1612861A Ecl labels having improved non-specific binding properties, methods of using and kits containing the same |
| 05/04/2005 | CN1612763A Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| 05/04/2005 | CN1612105A Processing instructions |
| 05/04/2005 | CN1611499A Heterocyclic compounds as inhibitors of rotamase enzymes |
| 05/03/2005 | US6888004 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 05/03/2005 | US6888000 Useful as immune response modifiers due to their ability to induce cytokine biosynthesis and otherwise modulate the immune reponse when administered to animals; viricides, antitumor agents |
| 05/03/2005 | US6887996 Compounds and their use |
| 05/03/2005 | US6887905 Treatment of depression or generalized anxiety disorder |
| 05/03/2005 | US6887892 Tricyclic derivatives of indole with antiangiogenic activity |
| 05/03/2005 | US6887889 Aryl and biaryl piperdines with MCH modulatory activity |
| 05/03/2005 | US6887885 Such as 3'-(5-methyl-4-oxo-4,5-dihydroimidazo(4,5-c)pyridin-1-yl)biphenyl-2 -carbonitrile; gamma-aminobutyric acid (GABA)-A receptors; for treating anxiety, convulsions and cognitive disorders |
| 05/03/2005 | US6887884 For therapy of neurological and psychological disorders |
| 05/03/2005 | US6887881 For use as antiarrhythmic drug |
| 05/03/2005 | US6887870 Useful as antianginal and cardioprotective agents; for therapy and prophylaxis of angina pectoris, cardiac dysfunction, myocardial necrosis, and arrhythmia |
| 05/03/2005 | CA2339594C Process for preparing n,n,6- trimethyl-2 -(4-methylphenyl)- imidazo-[1,2-a] -pyridine-3- acetamide and salts thereof |
| 05/03/2005 | CA2201477C New pyrimidone derivatives with antifungal activity |
| 05/03/2005 | CA2193994C Process for synthesis of substituted sulphoxides |
| 04/28/2005 | WO2005037954A1 New organic compound and organic light emitting device using the same |
| 04/28/2005 | WO2005037843A1 Compositions useful as inhibitors of protein kinases |
| 04/28/2005 | WO2005037834A1 NOVEL TETRAYDROSPIRO{PIPERIDINE-2,7’ -PYRROLO[3,2-b]PYRIDINE DERIVATIVES AND NOVEL INDOLE DERIVATIVES USEFUL IN THE TREATMENT OF 5-HT6 RECEPTOR -RELATED DISORDERS |
| 04/28/2005 | WO2005037833A1 4-amino-quinoline ouinolizidinyl-and quinolizidinylalkyl-derivatives with antimalarial activity |
| 04/28/2005 | WO2005037783A2 Use of tricyclic compounds as glycine transport inhibitors |
| 04/28/2005 | WO2005037271A2 Large conductance calcium-activated k channel opener |
| 04/28/2005 | WO2005037207A2 Arylalkyl-piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms (vms) |
| 04/28/2005 | WO2005037198A2 Preparation of 1,7-disubstituted azabenzimidazoles as kinase inhibitors |
| 04/28/2005 | WO2005037197A2 Preperation of 1,6-disubstituted azabenzimidazoles as kinase inhibitors |
| 04/28/2005 | WO2005037052A2 Binding assay with labelled bispidine variant |
| 04/28/2005 | WO2005007630A3 Aryl fused azapolycyclic compounds |
| 04/28/2005 | US20050090559 Heterocyclically-substituted pentanol derivatives, process for their production and their use as anti-inflammatory agents |
| 04/28/2005 | US20050090529 5-pyridin-3-yl-substituted, e.g., 5-(5-ethylaminomethyl-4-methylpyridin-3-yl)-3-(1H-imidazol-2-yl)-1H-indazole; CDK mediators, used to treat cancer, as well as proliferative diseases such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis |
| 04/28/2005 | US20050090526 3-Cyano-7-methoxy-4-(3-bromo-4,5-dimethoxyphenyl)-2-oxo-2H-chromene; 7-Amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-2-imino-2H-chromene; anticancer, antitumor agent |
| 04/28/2005 | US20050090523 2-(substituted phenyl)imidazo[1,2-a]pyridine compounds; use to treat disorders mediated by the histamine H3 receptor such as sleep disorders, attention deficit hyperactivity disorder, or Alzheimer's disease; 2-[4-[3-(Piperidino)propylamino]phenyl]-8-methylimidazo[1,2-a]pyridine for example |
| 04/28/2005 | US20050090522 E.g., 1-benzoyl-3-(R)-methyl-4-[(7-(4-fluorophenyl)-6-azaindol-3-yl)-oxoacetyl]piperazine; antiviral agents, especially for the treatment of HIV and AIDS, either used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. |
| 04/28/2005 | US20050090521 Tetrazoloquinoline, triazoloquinoline, and oxazoloquinoline compounds, e.g., 9-chloro-N-isopropoxytetrazolo[1,5-a]quinoline-4-carboxamide |
| 04/28/2005 | US20050090498 3-Quinolin-2(1h)-ylideneindolin-2-one derivative |
| 04/28/2005 | US20050090497 Novel ester or amide derivatives |
| 04/28/2005 | US20050090496 Sulphonyl compounds with 5-ht6 receptor affinity |
| 04/28/2005 | US20050090488 Drug combination for the treatment of depression and related disorders comprising mirtazapine |
| 04/28/2005 | US20050090483 Purine derivatives as kinase inhibitors |
| 04/28/2005 | US20050090472 Xanthine oxidase inhibitors |
| 04/28/2005 | US20050090450 enzyme inhibitors such as Pyrazine-2-carboxylic acid (cyclohexyl-{1-[2-(1-cyclopropylaminooxalyl-butylcarbamoyl)-3-isopropyl-pyrrolidine-1-carbonyl]-2,2-dimethyl-propylcarbamoyl}-methyl)-amide, used for treating viral diseases or pretreatment of medical equipment |
| 04/28/2005 | US20050089936 Such as 5-chloro-3-phenyl-1H-indole-2-carboxylic acid benzylamide; immobilization; drug screening |
| 04/28/2005 | US20050089935 Combinatorial library of 3-aryl-1h-indole-2-carboxylic acid |
| 04/28/2005 | US20050089718 Pyran derivative |
| 04/28/2005 | US20050089479 Delivery of sedative-hypnotics through an inhalation route |
| 04/28/2005 | CA2542113A1 Compositions useful as inhibitors of protein kinases |
| 04/28/2005 | CA2540861A1 Novel tetraydrospiro{piperidine-2,7' -pyrrolo[3,2-b]pyridine derivatives and novel indole derivatives useful in the treatment of 5-ht6 receptor -related disorders |
| 04/28/2005 | CA2539755A1 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 04/27/2005 | EP1526135A1 Azabenzodiazepines as pde4 inhibitors |
| 04/27/2005 | EP1525204A1 Phenylalanine enamide derivatives |
| 04/27/2005 | EP1525203A1 4-amino-substituted pyrimidine derivatives |
| 04/27/2005 | EP1525202A1 Novel 2,5-disubstituted pyrimidine derivatives |
| 04/27/2005 | EP1525181A1 Process for the preparation of phenylalanine enamide derivatives |
| 04/27/2005 | EP1524974A2 Transcription factor modulating compounds and methods of use thereof |
| 04/27/2005 | EP1244662B1 Pyridazino quinoline derivative and method for the treatment of pain |
| 04/27/2005 | EP1144411B1 Antihistaminic spiro compounds |
| 04/27/2005 | EP1040098B1 Integrin receptor antagonists |
| 04/27/2005 | EP1034173B1 Method for producing 8-methoxy-quinoline carboxylic acids |
| 04/27/2005 | EP0838453B1 Heterocyclic carboxylic acid derivatives and drugs containing the same |
| 04/27/2005 | CN1610681A Polycyclic compounds having anti-tumor activity |
| 04/27/2005 | CN1610666A Benzamidine derivative |
| 04/27/2005 | CN1610547A N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor |
| 04/27/2005 | CN1610546A 病毒聚合酶抑制剂 Viral polymerase inhibitor |
| 04/27/2005 | CN1198813C Benzofuran derivatives their preparation and use |
| 04/27/2005 | CN1198804C Amide compounds and use thereof |
| 04/27/2005 | CN1198803C Heterocyclic compounds having effect of activating nicoting acetylchloine alpha 4 beta 2 receptor |
| 04/27/2005 | CN1198612C Use of imidazo [1, 2-a] pyridine -3 -acetamide derivs. for therapeutic treatment of neuropsychiatric syndromes associated with disfunction of neural circuits of basal ganglia |
| 04/26/2005 | US6885026 Organic element for electroluminescent devices |
| 04/26/2005 | US6884889 Polymerase inhibitors; aid therapy |
| 04/26/2005 | US6884815 An amino compound containing imidazole and aromatic, or heteroaromatic rings is useful for treating inflammatory and immune system disorders |